O-5 INTEGRATED ANALYSIS OF ARCHAEAL, FUNGAL AND PROTOZOAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA
Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic signatures in MAFLD patients from Argentina. Stool samples, diet, demographic...
Saved in:
Published in | Annals of hepatology Vol. 28; p. 101015 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier España, S.L.U
01.03.2023
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1665-2681 2659-5982 |
DOI | 10.1016/j.aohep.2023.101015 |
Cover
Abstract | Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic signatures in MAFLD patients from Argentina.
Stool samples, diet, demographic and clinical data were obtained from 33 biopsy-proven MAFLD patients (12 simple steatosis (SS) / 21 steatohepatitis (SH)) and 19 healthy volunteers (HV). PNPLA3 rs738409 SNP was genotyped. RNA-seq was performed in NovaSeq6000®. Data were analyzed with Maaslin2-v1.2.0, bioBakery-v1.8 and DESeq2-v4.1.
BMI was higher among MAFLD patients than in HV (q=4.49 × 10−6). The risk GG genotype of PNPLA3-SNP was more prevalent among SH (q=0.0198). In MAFLD patients and in subjects with the GG genotype, differentially expressed genes (DEGs) of fungi, such as Fusarium proliferatum and Candida sorbophila, were up-regulated (q<0.01). After comparing transcript abundance, Saccharomucetaceae was the most active family among MAFLD patients, whereas Aspergillaceae family prevailed in HV. DEGs of methanogenic archaea and protozoa, such as Fonticula alba and Blastocystis spp., were highly expressed in MAFLD and SH after comparing them to HV and SS groups, respectively. The analysis of the functionally active protozoan families revealed that the Blastocystidae and Fonticulidae families were more functionally abundant in MAFLD and SH groups after comparing to HV and SS, respectively (Figure exhibits the statistically significant differences between groups). In subjects with the GG genotype, DEGs of Fonticula alba were up-regulated and those of Blastocystis spp. were less expressed after comparing to those with CC/CG genotypes. In SH, functional profiling of archaeal and fungal DEGs revealed an over-representation of viral capsid assembly and phage shock processes, whereas copper metabolism, peptidoglycan turnover and non-autophagic vacuolization were enriched by protozoan DEGs.
The switch in microbiome signatures characteristic of MAFLD onset and progression is achieved through the activity of several community members. |
---|---|
AbstractList | Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic signatures in MAFLD patients from Argentina.
Stool samples, diet, demographic and clinical data were obtained from 33 biopsy-proven MAFLD patients (12 simple steatosis (SS) / 21 steatohepatitis (SH)) and 19 healthy volunteers (HV). PNPLA3 rs738409 SNP was genotyped. RNA-seq was performed in NovaSeq6000®. Data were analyzed with Maaslin2-v1.2.0, bioBakery-v1.8 and DESeq2-v4.1.
BMI was higher among MAFLD patients than in HV (q=4.49 × 10−6). The risk GG genotype of PNPLA3-SNP was more prevalent among SH (q=0.0198). In MAFLD patients and in subjects with the GG genotype, differentially expressed genes (DEGs) of fungi, such as Fusarium proliferatum and Candida sorbophila, were up-regulated (q<0.01). After comparing transcript abundance, Saccharomucetaceae was the most active family among MAFLD patients, whereas Aspergillaceae family prevailed in HV. DEGs of methanogenic archaea and protozoa, such as Fonticula alba and Blastocystis spp., were highly expressed in MAFLD and SH after comparing them to HV and SS groups, respectively. The analysis of the functionally active protozoan families revealed that the Blastocystidae and Fonticulidae families were more functionally abundant in MAFLD and SH groups after comparing to HV and SS, respectively (Figure exhibits the statistically significant differences between groups). In subjects with the GG genotype, DEGs of Fonticula alba were up-regulated and those of Blastocystis spp. were less expressed after comparing to those with CC/CG genotypes. In SH, functional profiling of archaeal and fungal DEGs revealed an over-representation of viral capsid assembly and phage shock processes, whereas copper metabolism, peptidoglycan turnover and non-autophagic vacuolization were enriched by protozoan DEGs.
The switch in microbiome signatures characteristic of MAFLD onset and progression is achieved through the activity of several community members. Introduction and ObjectivesFungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic signatures in MAFLD patients from Argentina. Materials and MethodsStool samples, diet, demographic and clinical data were obtained from 33 biopsy-proven MAFLD patients (12 simple steatosis (SS) / 21 steatohepatitis (SH)) and 19 healthy volunteers (HV). PNPLA3 rs738409 SNP was genotyped. RNA-seq was performed in NovaSeq6000®. Data were analyzed with Maaslin2-v1.2.0, bioBakery-v1.8 and DESeq2-v4.1. ResultsBMI was higher among MAFLD patients than in HV (q=4.49 × 10 −6). The risk GG genotype of PNPLA3-SNP was more prevalent among SH (q=0.0198). In MAFLD patients and in subjects with the GG genotype, differentially expressed genes (DEGs) of fungi, such as Fusarium proliferatum and Candida sorbophila, were up-regulated (q<0.01). After comparing transcript abundance, Saccharomucetaceae was the most active family among MAFLD patients, whereas Aspergillaceae family prevailed in HV. DEGs of methanogenic archaea and protozoa, such as Fonticula alba and Blastocystis spp., were highly expressed in MAFLD and SH after comparing them to HV and SS groups, respectively. The analysis of the functionally active protozoan families revealed that the Blastocystidae and Fonticulidae families were more functionally abundant in MAFLD and SH groups after comparing to HV and SS, respectively (Figure exhibits the statistically significant differences between groups). In subjects with the GG genotype, DEGs of Fonticula alba were up-regulated and those of Blastocystis spp. were less expressed after comparing to those with CC/CG genotypes. In SH, functional profiling of archaeal and fungal DEGs revealed an over-representation of viral capsid assembly and phage shock processes, whereas copper metabolism, peptidoglycan turnover and non-autophagic vacuolization were enriched by protozoan DEGs. ConclusionsThe switch in microbiome signatures characteristic of MAFLD onset and progression is achieved through the activity of several community members. Introduction and Objectives: Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic signatures in MAFLD patients from Argentina. Materials and Methods: Stool samples, diet, demographic and clinical data were obtained from 33 biopsy-proven MAFLD patients (12 simple steatosis (SS) / 21 steatohepatitis (SH)) and 19 healthy volunteers (HV). PNPLA3 rs738409 SNP was genotyped. RNA-seq was performed in NovaSeq6000®. Data were analyzed with Maaslin2-v1.2.0, bioBakery-v1.8 and DESeq2-v4.1. Results: BMI was higher among MAFLD patients than in HV (q=4.49 × 10−6). The risk GG genotype of PNPLA3-SNP was more prevalent among SH (q=0.0198). In MAFLD patients and in subjects with the GG genotype, differentially expressed genes (DEGs) of fungi, such as Fusarium proliferatum and Candida sorbophila, were up-regulated (q<0.01). After comparing transcript abundance, Saccharomucetaceae was the most active family among MAFLD patients, whereas Aspergillaceae family prevailed in HV. DEGs of methanogenic archaea and protozoa, such as Fonticula alba and Blastocystis spp., were highly expressed in MAFLD and SH after comparing them to HV and SS groups, respectively. The analysis of the functionally active protozoan families revealed that the Blastocystidae and Fonticulidae families were more functionally abundant in MAFLD and SH groups after comparing to HV and SS, respectively (Figure exhibits the statistically significant differences between groups). In subjects with the GG genotype, DEGs of Fonticula alba were up-regulated and those of Blastocystis spp. were less expressed after comparing to those with CC/CG genotypes. In SH, functional profiling of archaeal and fungal DEGs revealed an over-representation of viral capsid assembly and phage shock processes, whereas copper metabolism, peptidoglycan turnover and non-autophagic vacuolization were enriched by protozoan DEGs. Conclusions: The switch in microbiome signatures characteristic of MAFLD onset and progression is achieved through the activity of several community members. |
ArticleNumber | 101015 |
Author | Trinks, Julieta Narvaez, Adrián Marro, Martin L. Mazzini, Flavia Noelia dez García, Celia Mén Haddad, Leila Suárez, Bárbara Cook, Frank Tamaroff, Ana Jesica Gutt, Susana Casciato, Paola Marciano, Sebastián Gounarides, John Mascardi, María Florencia Vera, M. Ruda Steinhardt, Alberto Penas Anders, Margarita Orozco, Federico Gadano, Adrián |
Author_xml | – sequence: 1 givenname: Bárbara surname: Suárez fullname: Suárez, Bárbara organization: 1 Institute of Translational Medicine and Biomedical Engineering (IMTIB) - Conicet University Institute of the Italian Hospital. Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 2 givenname: María Florencia surname: Mascardi fullname: Mascardi, María Florencia organization: 1 Institute of Translational Medicine and Biomedical Engineering (IMTIB) - Conicet University Institute of the Italian Hospital. Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 3 givenname: Flavia Noelia surname: Mazzini fullname: Mazzini, Flavia Noelia organization: 1 Institute of Translational Medicine and Biomedical Engineering (IMTIB) - Conicet University Institute of the Italian Hospital. Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 4 givenname: M. Ruda surname: Vera fullname: Vera, M. Ruda organization: Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research, Cambridge (NIBR), MA, United States of America – sequence: 5 givenname: Sebastián surname: Marciano fullname: Marciano, Sebastián organization: Liver Unit of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 6 givenname: Paola surname: Casciato fullname: Casciato, Paola organization: National Council for Scientific and Technical Research (CONICET), Buenos Aires, Argentina – sequence: 7 givenname: Adrián surname: Narvaez fullname: Narvaez, Adrián organization: Liver Unit of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 8 givenname: Leila surname: Haddad fullname: Haddad, Leila organization: Liver Unit of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 9 givenname: Margarita surname: Anders fullname: Anders, Margarita organization: Liver Unit of German Hospital, Buenos Aires, Argentina – sequence: 10 givenname: Federico surname: Orozco fullname: Orozco, Federico organization: Liver Unit of German Hospital, Buenos Aires, Argentina – sequence: 11 givenname: Ana Jesica surname: Tamaroff fullname: Tamaroff, Ana Jesica organization: Nutrition Department of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 12 givenname: Frank surname: Cook fullname: Cook, Frank organization: Analytical Sciences & Imaging Department, NIBR, Cambridge, MA, United States of America – sequence: 13 givenname: John surname: Gounarides fullname: Gounarides, John organization: Analytical Sciences & Imaging Department, NIBR, Cambridge, MA, United States of America – sequence: 14 givenname: Susana surname: Gutt fullname: Gutt, Susana organization: Nutrition Department of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 15 givenname: Adrián surname: Gadano fullname: Gadano, Adrián organization: Liver Unit of Buenos Aires Italian Hospital. Buenos Aires, Argentina – sequence: 16 givenname: Celia Mén surname: dez García fullname: dez García, Celia Mén organization: Chemical Biology & Therapeutics, NIBR, Cambridge, MA, United States of America – sequence: 17 givenname: Martin L. surname: Marro fullname: Marro, Martin L. organization: Cardiovascular and Metabolic Disease Area, NIBR, Cambridge, MA, United States of America – sequence: 18 givenname: Alberto Penas surname: Steinhardt fullname: Steinhardt, Alberto Penas organization: National Council for Scientific and Technical Research (CONICET), Buenos Aires, Argentina – sequence: 19 givenname: Julieta surname: Trinks fullname: Trinks, Julieta organization: 1 Institute of Translational Medicine and Biomedical Engineering (IMTIB) - Conicet University Institute of the Italian Hospital. Buenos Aires Italian Hospital. Buenos Aires, Argentina |
BookMark | eNqFkd-K1DAUh4Os4OzqE3iTSwU75k_TNohC7KTdQqdd2oyw3oQ0k2rHsV3aVdh38KFtZ8QLQfYqhxN-X3LOdwku-qF3ALzEaI0RDt4e1mb46u7WBBG6dBBmT8CKBIx7jEfkAqxwEDCPBBF-Bi6n6YCQTxkmK_Cr9BjMCiXTSii5gaIQ-W2d1bBMoKjiayFF_gYmuyIV-Xy5gTdVqcrPpShgulNQVaKo4yq7UeVWzhy4lUp8LPMshqKuyzg7QROh1C3Ms0-ygpuslqKW8NVWJPnm9ZIRVSoLlRXiOXjamuPkXvw5r8AukSq-9vIyzWKRe5bieYzIWUdYw0PqAhbxCEWWOtwS1FracL-ZS9K2lCNKcOTzxhjWYMctYczsmR_SK5CdufvBHPTd2H0344MeTKdPjWH8os1439mj0yy0AbE8xIiGPseI7wOKSeQz7NMQm2Bm0TPLjsM0ja79y8NIL3L0QZ_k6EWOPsuZU-_PKTeP-bNzo55s53rr9t3o7P38j-6R_Id_8vbY9Z01x2_uwU2H4cfYzxvUWE9EI10v-hf7hCKEMecz4N3_AY8-_xv3oLTa |
ContentType | Journal Article |
Copyright | 2023 |
Copyright_xml | – notice: 2023 |
DBID | 6I. AAFTH AAYXX CITATION DOA |
DOI | 10.1016/j.aohep.2023.101015 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2659-5982 |
EndPage | 101015 |
ExternalDocumentID | oai_doaj_org_article_57c62c97103749109d631284514371a6 10_1016_j_aohep_2023_101015 S1665268123001199 1_s2_0_S1665268123001199 |
GroupedDBID | --- .1- .FO 0R~ 1P~ 23M 2WC 53G 5GY 77H AAEDW AAKDD AALRI AAXUO AAYWO ABXHO ACVFH ADBBV ADCNI ADVLN AENEX AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APOWU APXCP BAWUL EBD EBS EMOBN F5P FDB GROUPED_DOAJ GX1 M41 OC. OK1 ON0 P2P ROL RSH SV3 TR2 Z5R AFCTW DIK NCXOZ 0SF 6I. AAFTH AAYXX CITATION |
ID | FETCH-LOGICAL-c3165-8ece25b973e6589808c3e1f20fc3b94b1f22ff390321849baa5b1e9c255ad5473 |
IEDL.DBID | DOA |
ISSN | 1665-2681 |
IngestDate | Wed Aug 27 01:17:04 EDT 2025 Wed Oct 01 01:35:08 EDT 2025 Thu Jul 20 20:09:28 EDT 2023 Sun Feb 23 10:19:43 EST 2025 Tue Aug 26 16:40:54 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3165-8ece25b973e6589808c3e1f20fc3b94b1f22ff390321849baa5b1e9c255ad5473 |
OpenAccessLink | https://doaj.org/article/57c62c97103749109d631284514371a6 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_57c62c97103749109d631284514371a6 crossref_primary_10_1016_j_aohep_2023_101015 elsevier_sciencedirect_doi_10_1016_j_aohep_2023_101015 elsevier_clinicalkeyesjournals_1_s2_0_S1665268123001199 elsevier_clinicalkey_doi_10_1016_j_aohep_2023_101015 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2023 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: March 2023 |
PublicationDecade | 2020 |
PublicationTitle | Annals of hepatology |
PublicationYear | 2023 |
Publisher | Elsevier España, S.L.U Elsevier |
Publisher_xml | – name: Elsevier España, S.L.U – name: Elsevier |
SSID | ssj0043512 |
Score | 2.3099437 |
Snippet | Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD... Introduction and ObjectivesFungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers... Introduction and Objectives: Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers... |
SourceID | doaj crossref elsevier |
SourceType | Open Website Index Database Publisher |
StartPage | 101015 |
SubjectTerms | Gastroenterology and Hepatology |
Title | O-5 INTEGRATED ANALYSIS OF ARCHAEAL, FUNGAL AND PROTOZOAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1665268123001199 https://www.clinicalkey.es/playcontent/1-s2.0-S1665268123001199 https://dx.doi.org/10.1016/j.aohep.2023.101015 https://doaj.org/article/57c62c97103749109d631284514371a6 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) customDbUrl: eissn: 2659-5982 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043512 issn: 1665-2681 databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2659-5982 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043512 issn: 1665-2681 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 2659-5982 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043512 issn: 1665-2681 databaseCode: AKRWK dateStart: 20020101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb5wwELaqHKpeqj7V7SPyIYdWChLYvHx0dmFDxUIE3irpxQJjlPawqbrpv-iPjseGaA9VcukNGTzAzHge8vgbhE6GYEyHOGaeGunohSoMPZZEvdcx4w1S0qdssNUWVXy-Db9eRpcHrb6gJszBAzvGmYRdxUSxBM6zhca3sSGmYFPB0SdBZ8G2jRubkylng00M4PY5Y1vDlQYz3pCt7OpurjVAVRIKIz50xD3wSRa6_8A1Hbib_AV6PsWJmLvve4me6N0r9HQz7YS_Rn9rL8KAZ7tuuDE-mFe8vGqLFtc5hg0gnvHyFOfbas1Lc3OFL5pa1N9rXuH1VmDR8KpdNsWFqDeZoYM3meBndVkssQV6LCzRnAtxhcviW9bgVdFmvM3w5w3Py9UXmMObdVaJouJv0DbPxPLcmzoreIoGhiWpVppEPUuoNhEIS_1UUR2MxB8V7VnYm0syjpT5FDJA1ndd1AeaKZN_dAN0K36LjnY3O_0O4SgNFCWd6jTg9AxRFyljN1RKhiQe_J4s0OnMW_nLAWjIubLsp7SikCAK6USxQGfA__tHAf3aDhidkJNOyMd0YoHCWXpyPmBqTKIh9OPhdyf_mqb307Ley0DuifRlC3oFamXyN8DMYwsU38-cIhcXkTz2yvf_43c_oGdA0hURf0RHt7__6E8mVLrtj-2quAM6V_zZ |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=O-5+INTEGRATED+ANALYSIS+OF+ARCHAEAL%2C+FUNGAL+AND+PROTOZOAN+GUT+TRANSCRIPTOME+IN+METABOLIC+ASSOCIATED+FATTY+LIVER+DISEASE+%28MAFLD%29+IN+ARGENTINA&rft.jtitle=Annals+of+hepatology&rft.au=Su%C3%A1rez%2C+B%C3%A1rbara&rft.au=Mascardi%2C+Mar%C3%ADa+Florencia&rft.au=Mazzini%2C+Flavia+Noelia&rft.au=Vera%2C+M.+Ruda&rft.date=2023-03-01&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=1665-2681&rft.volume=28&rft_id=info:doi/10.1016%2Fj.aohep.2023.101015&rft.externalDocID=S1665268123001199 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F16652681%2FS1665268123X00039%2Fcov150h.gif |